mRNA |
CHIR-99021 |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.04 |
mRNA |
MLN2480 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.04 |
mRNA |
NG-25 |
GDSC1000 |
pan-cancer |
AAC |
-0.063 |
0.04 |
mRNA |
WZ4002 |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.04 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.04 |
mRNA |
KU-55933 |
GDSC1000 |
pan-cancer |
AAC |
-0.075 |
0.05 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.05 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.05 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.05 |
mRNA |
Crizotinib |
CCLE |
pan-cancer |
AAC |
0.094 |
0.05 |